11/06/2025
Millions of Americans living with obesity face barriers to treatment—high costs and limited coverage have left many without the care they need. Thanks to advocates like you, today’s announcement marks a major step toward breaking down these barriers.
The Administration has announced agreements with pharmaceutical manufacturers to lower the cost of FDA-approved obesity medications. Medicare beneficiaries will now pay just $50/month, making these life-changing treatments more affordable and accessible, and opening the door for Medicare and Medicaid to cover obesity drugs for adults. Read the full blog here: https://bit.ly/4hLpWMh
Your voice matters! Help us continue this progress by sending a letter of thanks to the administration for prioritizing obesity care. Share your story to make an even bigger impact: https://bit.ly/496QYeP